Tag: SGLT-2 Inhibitor

Euglycemic DKA: It’s not a Myth

Background: Diabetic ketoacidosis (DKA) is traditionally defined as a triad of hyperglycemia (>250mg/dL), anion gap acidosis, and increased plasma ketones. There is another entity that providers must be aware of known as euglycemic DKA (euDKA), which is essentially DKA without …

Read More
Endocrine, Metabolic, Fluid, and Electrolytes